Although studies in SUDs, including CUD, AUD, and nicotine dependence, suggest potential reductions in cravings, inconsistencies in substance use and abstinence outcomes highlight the need to examine underlying neurobiological mechanisms, such as GLP‐1's role in dopamine regulation. This evidence concerns the gene GCG and nicotine dependence.